Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
SSKN | US
-0.08
-2.95%
Healthcare
Medical Instruments & Supplies
30/06/2024
04/10/2024
2.63
2.70
2.70
2.60
STRATA Skin Sciences Inc. a medical technology company develops commercializes and markets products for the treatment of dermatologic conditions in the United States Europe the Middle East Asia Australia South Africa and Central and South America. The company operates in two segments Dermatology Recurring Procedures and Dermatology Procedures Equipment. The company products include XTRAC and Pharos excimer lasers and VTRAC lamp systems for the treatment systems that are used for the treatment of psoriasis vitiligo and other skin conditions. It also provides TheraClear Acne Therapy System for the treatment of mild to moderate inflammatory comedonal and pustular acne. The company was formerly known as MELA Sciences Inc and changed its name to STRATA Skin Sciences Inc. in January 2016. STRATA Skin Sciences Inc. was incorporated in 1989 and is based in Horsham Pennsylvania.
View LessValue Stock (Price to Book < 3)
Negative Momentum (Declining Price)
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
High Debt to Equity (> 0.75)
Weak Operating Margin (< 10%)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
69.6%1 month
60.7%3 months
78.3%6 months
1369.2%-
-
1.30
1.74
0.42
-7.01K
0.71
-0.02
80.00K
10.97M
10.97M
-
-5.76
-
2.20
-62.97
0.28
0.10
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
0.60
Range1M
0.69
Range3M
1.29
Rel. volume
0.53
Price X volume
15.34K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Vivos Therapeutics Inc | VVOS | Medical Devices | 2.51 | 11.96M | 3.29% | n/a | 27.79% |
GCTK | GCTK | Medical Instruments & Supplies | 2.1586 | 11.83M | -4.02% | n/a | -8.33% |
NeuroMetrix Inc | NURO | Medical Instruments & Supplies | 4.1384 | 8.38M | -1.47% | n/a | 1.02% |
Nexalin Technology Inc. | NXL | Medical Devices | 0.6579 | 6.96M | 5.45% | n/a | 0.00% |
INBS | INBS | Medical Devices | 1.59 | 6.76M | 1.92% | n/a | 10.46% |
Sharps Technology Inc. | STSS | Medical Instruments & Supplies | 0.1524 | 4.36M | -0.78% | n/a | 0.00% |
Predictive Oncology Inc | POAI | Medical Instruments & Supplies | 0.6434 | 4.29M | -11.63% | n/a | 65.94% |
Acutus Medical Inc | AFIB | Medical Devices | 0.122 | 3.65M | 45.24% | n/a | -745.93% |
Common Stock | VERO | Medical Devices | 0.4488 | 3.26M | -12.00% | n/a | 1351.51% |
Talis Biomedical Corporation Common Stock | TLIS | Medical Devices | 1.78 | 3.24M | -6.32% | n/a | 38.66% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 0.695 | 8.47M | -4.15% | n/a | 16.03% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -7,008.83 | 7.69 | Cheaper |
Ent. to Revenue | 0.71 | 64.13 | Cheaper |
PE Ratio | - | 50.95 | - |
Price to Book | 1.30 | 6.11 | Cheaper |
Dividend Yield | - | 1.34 | - |
Std. Deviation (3M) | 78.33 | 55.82 | Riskier |
Debt to Equity | 1.74 | 0.86 | Expensive |
Debt to Assets | 0.42 | 0.26 | Expensive |
Market Cap | 10.97M | 9.95B | Emerging |